| (USD) | Dec 2020 | Y/Y change |
|---|---|---|
| Revenue | 29.15M | — |
| Operating expense | — | — |
| Net income | 0.00 | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, BPMUF returned +14.2% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +22.4% |
| 1 year | +14.2% |
| 5 years | +68.3% |
| 10 years | +11.2% |
| All-time high | $126.13 (Jun 2015) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in BPMUF would be worth today ›No. Basilea Pharmaceutica AG has not paid a dividend in the past 12 months.
Basilea Pharmaceutica AG is part of the Healthcare sector.
Basilea Pharmaceutica AG has a market cap of 957.95M USD, based on the latest quote.